financetom
Business
financetom
/
Business
/
GSK Says FDA Approves Rare Liver Disease Itch Drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GSK Says FDA Approves Rare Liver Disease Itch Drug
Mar 19, 2026 6:24 AM

09:04 AM EDT, 03/19/2026 (MT Newswires) -- GSK (GSK) said Thursday the US Food and Drug Administration has approved its experimental drug, Lynavoy, to treat cholestatic pruritus in adult patients with primary biliary cholangitis.

The company said the approval was based on a late-stage trial that showed the drug significantly reduced itching and related sleep disruption in patients compared with placebo.

Separately, GSK said its planned licensing deal with Alfasigma for the drug remains ongoing and subject to regulatory approvals.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved